Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury

• Published in: Biomedicine & pharmacotherapy Vol. 167; p. 115472
• Main Authors: Yi, Shuyuan, Cao, Hong, Zheng, Weilei, Wang, Yin, Li, Peifeng, Wang, Shoushi, Zhou, Zhixia
• Format: Journal Article
• Language: English
• Published: Elsevier Masson SAS 01.11.2023; Elsevier
• Subjects: Anti-inflammatory; Ca2; Ischemia-reperfusion (I/R) injury; Opioid receptor (OPR); Opioids; Remifentanil; NO; Cav-3; HDAC3; miRNAs; Opioid receptor (OPR); ERS; HIF-1α; I/R; TNF; Remifentanil; BCL-2; NF-κB; Opioids; ADRs; ZnT1; CaMKIIδ; AQP; PDIA3; RyR2; IL; OPRs; STAT3; LIF; PKC; SOD; MAPK; TNFR1; Ischemia-reperfusion (I/R) injury; ZEB1; FasL; JAK; Ca2; MTF1; IL-18BP; ROS; Bax; GPCR; iNOs; MPTP; TLR4; Anti-inflammatory; ERK
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.115472

Opioids are widely used in clinical practice by activating opioid receptors (OPRs), but their clinical application is limited by a series of side effects. Researchers have been making tremendous efforts to promote the development and application of opioids. Fortunately, recent studies have identified the additional effects of opioids in addition to anesthesia and analgesia, particularly in terms of organ protection against ischemia-reperfusion (I/R) injury, with unique advantages. I/R injury in vital organs not only leads to cell dysfunction and structural damage but also induces acute and chronic organ failure, even death. Early prevention and appropriate therapeutic targets for I/R injury are crucial for organ protection. Opioids have shown cardioprotective effects for over 20 years, especially remifentanil, a derivative of fentanyl, which is a new ultra-short-acting opioid analgesic widely used in clinical anesthesia induction and maintenance. In this review, we provide current knowledge about the physiological effects related to OPR-mediated organ protection, focusing on the protective effect and mechanism of remifentanil on I/R injury in the heart and other vital organs. Herein, we also explored the potential application of remifentanil in clinical I/R injury. These findings provide a theoretical basis for the use of remifentanil to inhibit or alleviate organ I/R injury during the perioperative period and provide insights for opioid-induced human organ protection and drug development. [Display omitted] •Opioids not only have anesthetic effects but also can protect against I/R injury.•Remifentanil inhibits calcium overload, inflammation, oxidative stress and apoptosis.•Remifentanil can reduce I/R injury of many important organs such as heart.•Remifentanil is potential candidate drug for alleviating clinical organ I/R injury.